Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

456
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
456
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

509
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
509
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

1.8K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

102
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
102
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

2.4K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.4K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

110
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
110

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Intravascular Imaging to Guide Percutaneous Coronary Interventions: Experience from a Single, High-Volume Canadian Centre.

CJC open·2026
Same author

An artificial intelligence prediction model for optimizing patient selection for cardiac imaging for the investigation of suspected coronary artery disease.

European heart journal. Digital health·2026
Same author

Occupational injury among firefighters in Canada: a trends analysis of fatality and time-loss injury claims (2007-2021).

Injury epidemiology·2025
Same author

Coronary Vasculitis in a Patient With IgG4RD and Possible EGPA Presenting With Acute Coronary Syndrome.

JACC. Case reports·2025
Same author

Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography for Low-Risk Patients Screened With Artificial Intelligence: Protocol for the CarDIA-AI Randomized Controlled Trial.

JMIR research protocols·2025
Same author

JUMPSTART: evaluation of an early mobilization program following transcatheter aortic valve replacement.

BMC cardiovascular disorders·2025

Related Experiment Video

Updated: Nov 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K

Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4)

Jon-David Schwalm1, Tara McCready1, Scott A Lear2

  • 1Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

CJC Open
|March 29, 2021
PubMed
Summary
This summary is machine-generated.

A community health intervention significantly reduced cardiovascular risk in older adults with hypertension. This approach, using health workers and technology, shows promise for improving heart health outcomes.

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Related Experiment Videos

Last Updated: Nov 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • A gap exists between evidence-based practices and clinical management of cardiovascular (CV) risk.
  • Community-based, multi-faceted interventions have shown potential in managing CV risk in hypertensive individuals.

Purpose of the Study:

  • To evaluate a community-based intervention (HOPE 4 Canada pilot study) aimed at reducing cardiovascular risk in individuals with hypertension.
  • To assess the effectiveness of simplified diagnostic/treatment algorithms, evidence-based recommendations, and social support in managing CV risk.

Main Methods:

  • A quasi-experimental, pre-post interventional study conducted in two Canadian communities.
  • Inclusion criteria: individuals aged ≥50 years with newly diagnosed or poorly controlled hypertension.
  • Intervention components: community health workers, decision support software, evidence-based medication and lifestyle advice, and social support.

Main Results:

  • Significant reduction in the 10-year cardiovascular disease risk estimate (Framingham Risk Score) from 30.6% to 24.7% (P < 0.01).
  • Significant decrease in systolic blood pressure from 153.1 to 136.7 mm Hg (P < 0.01).
  • No significant changes observed in lipid levels or healthy behaviors.

Conclusions:

  • A comprehensive, community-based intervention utilizing health workers and mobile-health technologies can effectively reduce cardiovascular risk.
  • Further research and evaluation are warranted to confirm these findings and explore broader implementation.